Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 15 of 15 for “"Sarcomatoid"”.
-
Investigating the Role of Hippo/Warts Signaling in Sarcomatoid Renal Cell Carcinoma
… and one of the most common cancers overall. Sarcomatoid RCC (sRCC) is a particularly aggressive subtype of RCC which displays a high rate of metastasis and poor prognosis, contributing to a disproportionately high clinical burden. Attempts to identify driver mutations of sarcomatoid …
-
Dissecting the role of aquaporin-1 (AQP1) and amiloride sensitive epitherial sodium channel (ENaC) in pleural mesothelioma biology
… type MPM (M14K), biphasc MPM (MSTO) and sarcomatoid MPM (ZL34)cells were used to characterize the phenotypes on homologous cell derived ECM or FNtreated substratum. AQP1 inhibition with HgCl2 abolished cell adhesion in MeT-5Aand M14K cells. Cell migration was lowered in ZL34 cells, TnT …
-
Μελέτη της επίδρασης του ωσμωτικού στρες στα μεσοθηλιακά κύτταρα του υπεζωκότα
… M14K; (epithelioid mesothelioma) and ZL34 (sarcomatoid mesothelioma). The range of osmolarity (250mOsm – 350mOsm) that was measured was used to apply hyperosmotic and hypoosmotic stress respectively. Our results suggest that hypoosmotic but not hyperosmotic stress decreased sheep parietal …
-
Inhibition of Hsp90 and its Client Kinase FAK has Therapeutic Potential in Squamous Cell Carcinomas of the Uterine Cervix and Oral Cavity
… high FAK expression was noted in oral SCC with sarcomatoid features. Thus, we conclude that Hsp90 inhibition has potential in the treatment of advanced and metastatic SCC of cervical and oral origin. The further examination of novel Hsp90-targeting compounds as well as strategies focused on …
-
Tumor Suppression by ARF in Carcinogen-Exposed Mice
… with many characteristics of pulmonary sarcomatoid carcinoma, a transitional tumor type previously undocumented in mice. Unexpectedly, urethane injection also resulted in the development of hepatic vascular tumors in <italic>Arf</italic>-deficient animals. Suppression of hemangioma …
-
Προγνωστικοί παράγοντες στο μεταπλαστικό καρκίνο του μαστού
… matrix-producing cells, spindle-shaped cells, or sarcomatoid or squamous differentiation. In most cases, MpBC lacks hormone receptor expression and carries a poor prognosis. Its incidence ranges from 0.2% to 5%. The Hippo signaling pathway has recently been associated with cancer progression and …
-
Epithelial-Mesenchymal Transition in Cancer – Relevance of Periostin Splice Variants
… tumor cells correlated with presence of sarcomatoid differentiation (p<0.001), higher tumor stage (p<0.001), lymph node metastases (p<0.05) and poor overall survival (p=0.009). In NSCLC, periostin mRNA levels correlated with the adenocarcinoma histotype (p<0.05). In epithelial tumor …
-
Ανάπτυξη και έλεγχος εγκυρότητας στατιστικών προγνωστικών μοντέλων ειδικής και ολικής επιβίωσης με τη μέθοδο κατασκευής νομογραμμάτων (nomograms) και ανάλυσης καμπύλης αποφάσεων (decision curve analysis), σε ασθενείς με σαρκωματοειδές ουροθηλιακό καρκίνωμα της ουροδόχου κύστεως
Ιntroduction: Sarcomatoid urothelial carcinoma (SUC) is a rare and aggressive variant of bladder cancer with limited data guiding prognosis. In this study, we present the first prognostic nomograms in the literature for the 3- and 5-year overall survival (OS) and disease-specific survival (DSS), …
-
Tumor microenvironment heterogeneity and novel therapeutic approaches in pleural mesothelioma
… as a frontline option, especially for the sarcomatoid subtype. However, despite these advancements, the benefits remain limited, with only a subset of patients responding to ICIs and a modest median overall survival improvement. Consequently, a new treatment paradigm combining chemotherapy …
-
Multi-Omics Understanding of Heterogeneity, Progression, and Therapeutic Vulnerabilities in Kidney Disease and Cancer
… value. Single nuclei RNA-seq of the adverse sarcomatoid and rhabdoid phenotypes uncover gene signatures and potential insights into tumor evolution. In vitro cell line studies confirm the potential of inhibiting identified phosphoproteome targets. We molecularly stratify aggressive …
-
Defining functional cooperation of oncogenic KRAS and rare driver mutations in intrahepatic cholangiocarcinom
… were representative of a rare and aggressive sarcomatoid subtype of iCCA. To understand how loss of both Trp53 and Nf2 leads to this aggressive phenotype, I used proteomic analysis of a number of signalling pathways, and RNA sequencing to define which mechanisms are altered and contribute to …
-
Identification of cancer stem cells in malignant pleural mesothelioma
… entwickelten, wiesen einen erhöhten Anteil an sarcomatoiden MPM auf. Dieser Sub-Typ ist der aggressivere der MPM Sub-Typen und ähnelt einem Vorläuferzellen-Phänotyp. Ein erhöhter Anteil an sarcomatoiden Mesotheliomzellen wurde auch in wiederkehrenden Tumoren von Patienten festgestellt. Zudem …
-
Characterization of murine pancreatic carcinoma models regarding immunosuppressive mechanisms and therapy with bifunctional siRNA targeting galectin-1
… In contrast, Panc02 tumors were found to have a sarcomatoid architecture with very little tumor stroma. In Panc02 cells, galectin-1 was strongly expressed by the tumor cells, which differs from the situation found in humans, KPC mice and T110299 tumors, where galectin-1 is preferentially …
-
Determination of p53 role in cancer biology and therapy through interactome development and analysis
… be exploited for greater therapeutic efficacy in sarcomatoid, and CYP24A1, HIPK4 and PEG3 in biphasic p53 (+/+) malignant mesothelioma tumours. Drug profile analysis of deregulated genes identified by the model highlight the need for individualised therapeutic approaches, and we offer putative …